Pro-Inflammatory Cytokines in Patients With Chronic Phase-Chronic Myeloid Leukaemia Treated With Imatinib: Any Role in the Monitoring of Treatment Response?
The study has concluded that treatment naïve CML is associated with a significant elevation of pro-inflammatory cytokines (IL-6 and CRP) and treatment with imatinib led to a significant decline in the serum levels of these markers suggesting that IL-6 and CRP could be useful as adjunct in the monitoring of CML treatment.
Authors
- Olusola Olarewaju
- Ibrahim O. Ahmed (ORCID: https://orcid.org/0000-0001-7571-345X)
- Rahman A. Bolarinwa (ORCID: https://orcid.org/0000-0003-2782-7190)
- Kehinde A. Taiwo (ORCID: https://orcid.org/0000-0003-4353-8591)
- Temilola O. Owojuyigbe (ORCID: https://orcid.org/0000-0003-3977-2326)
- Muritala Abiola Asafa
- Oludolapo Abidemi Omoyiola
- Olatokunbo O. Oguns
Institutions
- Obafemi Awolowo University Teaching Hospitals Complex (NG)
- Obafemi Awolowo University (NG)
Publication Details
- Journal
- Biomarker Insights
- Published
- 2025-06-30
- DOI
- https://doi.org/10.1177/11772719251351687
- Citations
- 2
- Primary Topic
- Chronic Myeloid Leukemia Treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.54